Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Bromberg

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancer Discovery|November 10, 2025
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and BindingWanyi Chen, Avantika Gupta, Nicholas Mai, et al.
JACC. Cardiooncology|June 19, 2025
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted TherapyAnthony F Yu, Chau T Dang, Chaya S Moskowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancerPasquale Sansone, Claudia Savini, Ivana Kurelac, et al.
Cancer Research|February 17, 2017
Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal MicrovesiclesPasquale Sansone, Marjan Berishaj, Vinagolu K Rajasekhar, et al.
The Journal of Clinical Investigation|April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of gliomaYujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.
Breast Cancer Research and Treatment|August 20, 2022
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility studyElaine M Walsh, Ayca Gucalp, Sujata Patil, et al.
Nature Communications|April 30, 2015
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturationMarianna Papaspyridonos, Irina Matei, Yujie Huang, et al.
Radiology|February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-FluoroglutamineMark P S Dunphy, James J Harding, Sriram Venneti, et al.
Cancer Discovery|January 10, 2015
JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic responseMaria Kleppe, Minsuk Kwak, Priya Koppikar, et al.
Nature Communications|February 10, 2016
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancerPasquale Sansone, Claudio Ceccarelli, Marjan Berishaj, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Discovery|November 10, 2025
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and BindingWanyi Chen, Avantika Gupta, Nicholas Mai, et al.
JACC. Cardiooncology|June 19, 2025
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted TherapyAnthony F Yu, Chau T Dang, Chaya S Moskowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancerPasquale Sansone, Claudia Savini, Ivana Kurelac, et al.
Cancer Research|February 17, 2017
Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal MicrovesiclesPasquale Sansone, Marjan Berishaj, Vinagolu K Rajasekhar, et al.
The Journal of Clinical Investigation|April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of gliomaYujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.
Breast Cancer Research and Treatment|August 20, 2022
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility studyElaine M Walsh, Ayca Gucalp, Sujata Patil, et al.
Nature Communications|April 30, 2015
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturationMarianna Papaspyridonos, Irina Matei, Yujie Huang, et al.
Radiology|February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-FluoroglutamineMark P S Dunphy, James J Harding, Sriram Venneti, et al.
Cancer Discovery|January 10, 2015
JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic responseMaria Kleppe, Minsuk Kwak, Priya Koppikar, et al.
Nature Communications|February 10, 2016
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancerPasquale Sansone, Claudio Ceccarelli, Marjan Berishaj, et al.
Pageof 6